SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-010719
Filing Date
2023-01-19
Accepted
2023-01-19 09:23:33
Documents
16
Period of Report
2023-01-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d433505d8k.htm   iXBRL 8-K 63903
2 EX-2.1 d433505dex21.htm EX-2.1 603296
3 EX-99.1 d433505dex991.htm EX-99.1 35779
7 GRAPHIC g433505g01d72.jpg GRAPHIC 12628
8 GRAPHIC g433505g02d73.jpg GRAPHIC 11756
  Complete submission text file 0001193125-23-010719.txt   1036932

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cnce-20230118.xsd EX-101.SCH 2868
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnce-20230118_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnce-20230118_pre.xml EX-101.PRE 11273
10 EXTRACTED XBRL INSTANCE DOCUMENT d433505d8k_htm.xml XML 3358
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36310 | Film No.: 23536093
SIC: 2834 Pharmaceutical Preparations